Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,239.30 +232.03 1.78%
Hang Seng 21,052.00 -173.90 -0.82%
S&P/ASX 200 4,861.40 +47.05 0.98%
  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Infinity Pharmaceuticals Inc

+ Add to Watchlist

INFI:US

19.4600 USD 2.2900 13.34%

As of 20:10:00 ET on 06/18/2013.

Company Profile for Infinity Pharmaceuticals Inc (INFI)

Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.

Contact Information

Infinity Pharmaceuticals Inc

780 Memorial Drive
Cambridge, MA 02139
United States
Phone: 1-617-453-1000
Fax: 1-617-453-1001

Key Executives for Infinity Pharmaceuticals Inc (INFI)

Adelene Q PerkinsChairman/President/CEOVito J PalombellaChief Scientific Officer
Pedro SantabarbaraChief Medical OfficerJulian AdamsPres:Research & Development
Lawrence E Bloch "Larry"Exec VP/CFO/Chief Bus Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil